Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis.
Saudi Pharm J
; 28(12): 1605-1615, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-33424253
3'UTR, 3' untranslated region; ActinD, actinomycin D; Ahr; Ahr, aryl hydrocarbon receptor; Arid5a; Arid5a, AT-rich interactive domain-containing protein 5a; Arnt, Ahr nuclear translocator; Autoimmunity; CFA, complete Freund's adjuvant; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; Inflammation; LPS, lipopolysaccharide; MOG35-55, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; Multiple sclerosis; PAS-A and PAS-B, Per-Arnt-Sim domain; RBP, RNA-binding protein; RIP, RNA immunoprecipitation; SPF, specific pathogen-free; Therapeutic; miR, microRNA
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Saudi Pharm J
Year:
2020
Type:
Article
Affiliation country:
Saudi Arabia